An overview of Ca Gall bladder management .ppt

AmitPodder6 59 views 21 slides Sep 12, 2024
Slide 1
Slide 1 of 21
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21

About This Presentation

Ca gall bladder


Slide Content


A rare disease but extremely variable A rare disease but extremely variable
by geographical region racial groupsby geographical region racial groups

Highest incidence in Chileans, Highest incidence in Chileans,
American Indians and in parts of American Indians and in parts of
northern India where it accounts for as northern India where it accounts for as
much as 9.1% of all gall bladder much as 9.1% of all gall bladder
disease.disease.


In west gall bladder cancer accounts In west gall bladder cancer accounts
for less than 1% of new cancer for less than 1% of new cancer
diagnosis diagnosis


Actual – unknown Actual – unknown

Predisposing factors-Predisposing factors-
Age – elderlyAge – elderly
G. Stone (10-25% of cases)G. Stone (10-25% of cases)
Chr. cholecystitisChr. cholecystitis


Histological types:Histological types:
Adenocarcnoma – commonest (90%)Adenocarcnoma – commonest (90%)
Squamous cell carcinoma – rare Squamous cell carcinoma – rare
Adeno-sqamous – rarestAdeno-sqamous – rarest


Spread:Spread:
Direct-Direct-
liverliver
adjacent organsadjacent organs
Lymphatic-Lymphatic-
lymph nodes in Callot’s trianglelymph nodes in Callot’s triangle
para-aortic (coeliac) L. nodespara-aortic (coeliac) L. nodes
Haematogenous-Haematogenous-
liverliver
distant metastasis - raredistant metastasis - rare


Mode of presentation:Mode of presentation:

AsymptomaticAsymptomatic – diagnosed during- – diagnosed during-
cholecystectomy for G. stonecholecystectomy for G. stone
routine histologyroutine histology


When the tumour obstructs cystic duct, the When the tumour obstructs cystic duct, the
patient presents with features of-patient presents with features of-
acute cholecystitis oracute cholecystitis or
Mucocele Mucocele


> 50% patients present with features > 50% patients present with features
of-of-
Obstructive jaundiceObstructive jaundice
Palpable mass in RHCPalpable mass in RHC

At the time of presentation majority of At the time of presentation majority of
tumours are advancedtumours are advanced


Ca pancreasCa pancreas

Cholangio-carcinomaCholangio-carcinoma

HepatomaHepatoma

Ca stomachCa stomach

Ca colonCa colon


U/S of HBSU/S of HBS

CT scan – if U/S is inconclusiveCT scan – if U/S is inconclusive

MRI – if CT inconclusiveMRI – if CT inconclusive

Image guided biopsyImage guided biopsy

Laparoscopic biopsyLaparoscopic biopsy

CA19-9 is elevated in 80% of patientsCA19-9 is elevated in 80% of patients


If diagnosed during chlecystectomy – If diagnosed during chlecystectomy – some some
advices resection of adjacent part of liveradvices resection of adjacent part of liver

In other cases – In other cases – only palliation by-only palliation by-
stenting if there is obst. jaundicestenting if there is obst. jaundice
chemotherapychemotherapy
pain killerpain killer


5 year survival5 year survival
2 – 5% overall 2 – 5% overall
50% if the tumour is confined to mucosa50% if the tumour is confined to mucosa

21
Tags